drugset / Trial / NCT04783870
Effect of Dapagliflozin on LV Remodeling Post AMI
RandomizedParallel-groupDouble-blindTreatment
Summary
The overall hypothesis of the study is that Dapagliflozin will reduce left ventricular remodeling in patients who have had a myocardial infarction.
Timeline
- Start
- 2021-03-03
- Primary completion
- 2023-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapagliflozin | Small molecule | 10 mg | Oral |